
Boston Scientific
300 Boston Scientific Way, Marlborough, MA, 01752, United States
Overview
Innovative medical solutions for less-invasive diagnosis and treatment.
Founded
1979
Deals ยท 12mo
1
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
MiRus | May 2026Led | $1.5 BOther Equity | |
SetPoint Medical | Aug 2025Participated | $140 MSeries D | |
Nectero Medical | Apr 2024Participated | $96 MSeries D | |
Nectero Medical | Sep 2021Led | $20 MSeries C | |
SetPoint Medical | Jan 2021Participated | $64 MOther Equity | |
Preventice Solutions | Jul 2020Participated | $137 MSeries B | |
Saluda Medical | Jun 2019Participated | $75 MOther Equity | |
InterVene | Jun 2019Participated | $15 MSeries B | |
Francis Medical | Dec 2018Participated | $18 MSeries A | |
RenovoRx | May 2018Led | $10 MOther Equity | |
SetPoint Medical | Aug 2017Participated | $30 MSeries D | |
Channel Medsystems | Aug 2017Participated | $14 MSeries C | |
MiRus | May 2026Led | $1.5 BOther Equity | |
SetPoint Medical | Aug 2025Participated | $140 MSeries D | |
Nectero Medical | Apr 2024Participated | $96 MSeries D | |
Nectero Medical | Sep 2021Led | $20 MSeries C | |
SetPoint Medical | Jan 2021Participated | $64 MOther Equity | |
Preventice Solutions | Jul 2020Participated | $137 MSeries B | |
Saluda Medical | Jun 2019Participated | $75 MOther Equity | |
InterVene | Jun 2019Participated | $15 MSeries B | |
Francis Medical | Dec 2018Participated | $18 MSeries A | |
RenovoRx | May 2018Led | $10 MOther Equity | |
SetPoint Medical | Aug 2017Participated | $30 MSeries D | |
Channel Medsystems | Aug 2017Participated | $14 MSeries C |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 1 | 1 |
| Series B | 2 | 2 |
| Series C+ | 2 | 6 |
| Other Equity | 5 | 4 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Dec '08 | 1 |
| Jan '09 | 0 |
| Feb '09 | 0 |
| Mar '09 | 0 |
| Apr '09 | 0 |
| May '09 | 0 |
| Jun '09 | 0 |
| Jul '09 | 0 |
| Aug '09 | 0 |
| Sep '09 | 0 |
| Oct '09 | 0 |
| Nov '09 | 0 |
| Dec '09 | 0 |
| Jan '10 | 0 |
| Feb '10 | 0 |
| Mar '10 | 0 |
| Apr '10 | 0 |
| May '10 | 0 |
| Jun '10 | 0 |
| Jul '10 | 0 |
| Aug '10 | 0 |
| Sep '10 | 0 |
| Oct '10 | 0 |
| Nov '10 | 0 |
| Dec '10 | 0 |
| Jan '11 | 0 |
| Feb '11 | 0 |
| Mar '11 | 0 |
| Apr '11 | 0 |
| May '11 | 0 |
| Jun '11 | 0 |
| Jul '11 | 0 |
| Aug '11 | 0 |
| Sep '11 | 0 |
| Oct '11 | 0 |
| Nov '11 | 0 |
| Dec '11 | 0 |
| Jan '12 | 0 |
| Feb '12 | 0 |
| Mar '12 | 0 |
| Apr '12 | 0 |
| May '12 | 0 |
| Jun '12 | 0 |
| Jul '12 | 1 |
| Aug '12 | 0 |
| Sep '12 | 0 |
| Oct '12 | 0 |
| Nov '12 | 0 |
| Dec '12 | 0 |
| Jan '13 | 0 |
| Feb '13 | 1 |
| Mar '13 | 0 |
| Apr '13 | 0 |
| May '13 | 1 |
| Jun '13 | 0 |
| Jul '13 | 0 |
| Aug '13 | 1 |
| Sep '13 | 0 |
| Oct '13 | 0 |
| Nov '13 | 1 |
| Dec '13 | 0 |
| Jan '14 | 0 |
| Feb '14 | 0 |
| Mar '14 | 0 |
| Apr '14 | 0 |
| May '14 | 0 |
| Jun '14 | 0 |
| Jul '14 | 0 |
| Aug '14 | 0 |
| Sep '14 | 0 |
| Oct '14 | 0 |
| Nov '14 | 0 |
| Dec '14 | 0 |
| Jan '15 | 0 |
| Feb '15 | 0 |
| Mar '15 | 1 |
| Apr '15 | 0 |
| May '15 | 0 |
| Jun '15 | 0 |
| Jul '15 | 0 |
| Aug '15 | 1 |
| Sep '15 | 0 |
| Oct '15 | 1 |
| Nov '15 | 0 |
| Dec '15 | 1 |
| Jan '16 | 0 |
| Feb '16 | 0 |
| Mar '16 | 0 |
| Apr '16 | 0 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 0 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 1 |
| Aug '17 | 2 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 1 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 1 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 2 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 1 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 1 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 1 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 1 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 23 |
| Consumer & Lifestyle | 3 |
| Manufacturing | 2 |
| Fintech | 1 |
| Space & Frontier Tech | 1 |
| Developer Tools | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 2 |
| $10M-$25M | 9 |
| $25M-$50M | 5 |
| $50M-$100M | 3 |
| $100M-$250M | 2 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 1 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 22 |
| Israel | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Action Potential Venture Capital | 4 |
| Morgenthaler Ventures | 4 |
| Arboretum Ventures | 3 |
| InCube Ventures | 3 |
| New Enterprise Associates | 3 |
| Scientific Health Development | 3 |
| Ally Bridge Group | 2 |
| Aperture Venture Partners | 2 |
| Ascendum Capital | 2 |
| Catalio Capital Management | 2 |
| Euclidean Capital | 2 |
| Longwood Fund | 2 |
| Midas Capital | 2 |
| Norwest Venture Partners | 2 |
| Richard King Mellon Foundation | 2 |
| RiverVest Venture Partners | 2 |
| Sante Ventures | 2 |
| ShangBay Capital | 2 |
| Third Point Ventures | 2 |
| 3x5 Partners | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 10 | 43% |
| Participating | 13 | 57% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 7 | 70% |
| Co-led | 3 | 30% |
Team
Sr. Program Manager
Executive Vice President, President EMEA
Executive Vice President and Global Chief Medical Officer
Vice President, US Sales Enablement
Executive Vice President and President, Peripheral Interventions
Founder
Director Level Positions
SVP and President, Interventional Cardiology Therapies
IP Counsel
Executive Vice President HR